Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
16 14 Search
2025
ELOC-Mutated Renal Cell Carcinoma is a Rare Indolent Tumor With Distinctive Genomic Characteristics
Modern Pathology
2024
Experience of the first adult-focussed undiagnosed disease program in Australia (AHA-UDP): solving rare and puzzling genetic disorders is ageless
Orphanet Journal of Rare Diseases
2024
Computational analysis of protein–protein interactions of cancer drivers in renal cell carcinoma
FEBS Open Bio
2023
Expression analysis of hsa_circ_0020397, hsa_circ_0005986, hsa_circ_0003028, and hsa_circ_0006990 in renal cell carcinoma
Experimental and Molecular Pathology
2023
Network diffusion-based approach for survival prediction and identification of biomarkers using multi-omics data of papillary renal cell carcinoma
Molecular Genetics and Genomics
2023
Tumor-suppressive functions of protein lysine methyltransferases
Experimental & Molecular Medicine
2023
Loss of SETD2‐mediated downregulation of intracellular and exosomal miRNA‐10b determines MAPK pathway activation and multidrug resistance in renal cancer
Molecular Carcinogenesis
2022
Cancer stem/progenitor signatures refine the classification of clear cell renal cell carcinoma with stratified prognosis and decreased immunotherapy efficacy
Molecular Therapy - Oncolytics
2022
Structural insight into ASH1L PHD finger recognizing methylated histone H3K4 and promoting cell growth in prostate cancer
Frontiers in Oncology
2022
Lysine Methyltransferase NSD1 and Cancers: Any Role in Melanoma?
Cancers
2022
idenMD-NRF: a ranking framework for miRNA-disease association identification
Briefings in Bioinformatics
2021
Causal integration of multi‐omics data with prior knowledge to generate mechanistic hypotheses
Molecular Systems Biology
2021
Transcription Factors BARX1 and DLX4 Contribute to Progression of Clear Cell Renal Cell Carcinoma via Promoting Proliferation and Epithelial–Mesenchymal Transition
Frontiers in Molecular Biosciences
2020
Novel molecular signatures and potential therapeutics in renal cell carcinomas: Insights from a comparative analysis of subtypes
Genomics
2020
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
Nature Medicine
Additional cited-by details will be shown when available from Crossref